Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-288119
Filing Date
2015-08-12
Accepted
2015-08-12 16:18:55
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d59201d10q.htm 10-Q 563691
2 EX-10.1 d59201dex101.htm EX-10.1 207204
3 EX-31.1 d59201dex311.htm EX-31.1 6345
4 EX-31.2 d59201dex312.htm EX-31.2 6382
5 EX-32.1 d59201dex321.htm EX-32.1 2982
6 EX-32.2 d59201dex322.htm EX-32.2 3015
  Complete submission text file 0001193125-15-288119.txt   3254223

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT life-20150630.xml EX-101.INS 499033
8 XBRL TAXONOMY EXTENSION SCHEMA life-20150630.xsd EX-101.SCH 34245
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20150630_cal.xml EX-101.CAL 52146
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20150630_def.xml EX-101.DEF 133069
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20150630_lab.xml EX-101.LAB 310691
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20150630_pre.xml EX-101.PRE 223168
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 151047229
SIC: 2836 Biological Products, (No Diagnostic Substances)